Demetrios L. Kouzoukas - 15 May 2023 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
Director
Signature
Josheph R. Martin, Attorney-in-Fact
Issuer symbol
CLOV
Transactions as of
15 May 2023
Net transactions value
$0
Form type
4
Filing time
16 May 2023, 21:39:11 UTC
Previous filing
05 Jan 2023
Next filing
05 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Award $0 +36,585 +16% $0.000000 259,455 15 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on the first anniversary of May 15, 2023, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.